Servier Sea Cluster company information, Employees & Contact Information

Servier Presentations at ASCO 2025 Reinforce Company Leadership in IDH-Mutated Cancers PR Newswire

Integrated annual report 2023/2024 Servier

Biogaran sale talks renew fears over foreign control of French pharma RFI

JPM25: As Servier cements oncology bona fides, US chief stresses importance of 'staying authentic' Fierce Pharma

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030 Servier

Drugmaker Servier loses EU court fight over pay-for-delay deals Reuters

Servier eyes up Ideaya’s darovasertib | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

The Servier Case: The Game isn’t Over Yet Dechert

Soldier sold £75k of equipment ‘attractive to terrorists’ on eBay The Telegraph

Servier Ranked Among Top Companies Across Several Categories in 2024 PatientView Corporate Reputation of Pharma Survey PR Newswire

Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition Servier

Servier Showcases Robust Presence at ASH 2019 PR Newswire

Our commitment to neurology Servier

See our bases throughout the world Servier

Our ambition for 2030 Servier

Servier reveals a new visual identity Servier

The season for hiring PhD students has officially begun at Servier! Servier

Servier co-sponsor of the Paris-Saclay SPRING Servier

Our commitment to oncology Servier

Schema describing Servier’s governance structure Servier

Servier Announces Expansion of its Tibsovo (ivosidenib) Development Program Investigating its Safety and Efficacy in Patients Living with IDH1-Mutated Cancers in Both Hematological Malignancies and Solid Tumors PR Newswire

Servier acquires treatment for autism genetic cause Fragile X syndrome European Pharmaceutical Review

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M Fierce Pharma

French drug maker Servier sets up U.S. headquarters in Boston’s Seaport statnews.com

French drug company Servier launches Mediator appeal Reuters

Servier’s US push takes shape as Boston HQ opens BioPharma Dive

Servier severing forces OPM to make 'drastic choices' to adapt as it cuts staff, executive wages Fierce Biotech

Servier Buys Fragile X Syndrome Candidate for up to $450M Genetic Engineering and Biotechnology News

French pharma firm found guilty over medical scandal in which up to 2,000 died The Guardian

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs (Published 2014) The New York Times

Servier's beefing up in oncology through dealmaking and Tibsovo wins—and it's not done yet, U.S. CEO says Fierce Pharma

Servier unveils its 2030 ambition and reveals a new visual identity PR Newswire UK

Missing Sevier Co. man found safe WBIR

UK Supreme Court rules in favour of Servier in NHS patent lawsuit PMLiVE

MVA member company 2N Pharma won the Servier Golden Ticket! mva.org

Servier completes the acquisition of MVA-member company Symphogen mva.org

Former Ruffer director Harry Sevier launches Lulworth Investment Management Investment Week

French pharmaceutical company appeals conviction over weight-loss drug RFI

France shaken by fresh scandal over weight-loss drug linked to deaths The Guardian

France braced for diabetic drug scandal report BBC

Servier UK appoints new chief executive Pharmafile

Seven Monckton barristers act for NHS claimants in milestone judgment against pharma company Servier in its attempt to limit damages in “pay for delay” perindopril case Monckton Chambers

Arklow pharmaceutical company opens its doors to chamber members The Irish Independent

Servier awards Sodexo dining contract for Arklow offices The Irish Independent